×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 6 - Track C: Simplifying Clinical Trial Execution in Canada in the Interest of Patients
Session Chair(s)
Janice Lobo-Dale
Regulatory Analyst, Biologics and Genetic Therapies Directorate
Health Canada, Canada
Learning Objective : Attendees will learn how to: Apply the principles of “good practice” project management within the regulated clinical and pharmaceutical environment Understand the role of risk management and how it should be integrated into each aspect of a project Utilize tested techniques and lessons learned for combating clinical and pharmaceutical project challenges.
Speaker(s)
Best Practices for Managing Succesful Clinical & Pharmaceutical Projects
Zizi Imatorbhebhe, MBA, MS, PMP
Select One, United States
Executive Partner
Clinical Trials in Canada: Extraterritorial Application of US Laws and Regulations
Jack Corman
JHC Consulting, Canada
The Initiative to Streamline Investigator Initiated Clinical Trials: Guidelines for Managing Canadian Regulatory Expectations
Karen Arts, BSN, MSN, RN
Ontario Institute For Cancer Research, Canada
Director, Business Development, High Impact Clinical Trials
Have an account?